$ISRG

Why is Intuitive Surgical stock sliding today?

Intuitive Surgical (ISRG) stock fell 7.3% in after-hours trading to $406 after reporting a $450M pre-tax charge for an antitrust settlement, reducing GAAP net income to $523M ($1.49 EPS) from $704M ($1.95 EPS) YoY. Adjusted EPS beat estimates at $3.00, with revenue up 22% to $3.05B. Procedure volumes and system placements grew, but guidance remained unchanged, signaling decelerating momentum.

Original reporting
Published Oct 20, 2026, 8:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 8:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ISRG
Bearish
high confidence
Mentioned
$ISRG
Relevance
9/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ISRGBearishHigh
01

Why it matters

The settlement caused a sharp share decline despite strong adjusted earnings and revenue growth.

02

Market read

The earnings miss and settlement charge are material for ISRG and may influence med‑tech sector sentiment.

03

What to watch

Potential long‑term demand for da Vinci systems and instrument revenue could offset short‑term hit.

Relevance 9/10Novelty 9/10Timing: after-hours today

Background

Intuitive Surgical's Q3 earnings were released after market close, highlighting a large antitrust settlement charge.

Company-level read

Ticker impact

$ISRGBearishHigh confidence
Context

Intuitive Surgical reported Q3 2026 earnings with a $450M pre‑tax antitrust settlement charge, causing a 7.3% after‑hours drop to $406.

Expected impact

likely further decline as investors price in the GAAP earnings miss and reduced margin guidance

Evidence & confidence

A sizable one‑time charge and unchanged guidance signal weaker momentum, prompting sell‑offs.

Market effects

Medical device sector may face heightened scrutiny and valuation pressure.

U.S. markets may see broader tech/healthcare sell‑off in after‑hours trading.

Limited to U.S. listed med‑tech stocks; no immediate global macro impact.

Counterpoint

Some investors may view the adjusted earnings beat and strong procedure growth as a buying opportunity if the settlement is truly one‑off.

Key entities

  • Intuitive Surgical

    US‑listed medical device maker of da Vinci surgical robots.

Related articles

$ISRGHighAI 8/10

Stocks making the biggest moves after hours: Super Micro Computer, Intuitive Surgical, Netflix, SpaceX & more

Intuitive Surgical (ISRG) fell 10% after Q3 results missed expectations, while SpaceX shares rose 2% on a 161% revenue jump. Netflix (NFLX) dropped 5% despite in-line sales. Capital One (COF) gained 5% on higher net income. United Airlines (UAL) declined 2% after earnings trailed estimates. Super Micro Computer (SMCI) surged 12% on an upgraded revenue outlook.

$NFLXMed

After-Hours Movers: NFLX, SPCX, SMCI, ISRG, COF, UAL, PEGA

Netflix (NFLX) fell 5% after Q3 beat but soft Q4 guidance. SpaceX (SPCX) rose 1.5% on 161% revenue growth. Intuitive Surgical (ISRG) dropped 11% despite strong results. Capital One (COF) jumped 5% on Q3 earnings. United Airlines (UAL) fell 2% after missing estimates. Pegasystems (PEGA) slid 5% on weak Q3 report. Supermicro (SMCI) surged 12% on raised guidance.

$ISRGHighAI 8/10

Intuitive Surgical slides 13% as earnings hit by pre-tax charge

Intuitive Surgical (ISRG) reported Q3 earnings of $3.00 per share, beating estimates by $0.35, with revenue up 22% YoY to $3.05B. Shares fell 13.2% due to a $450M pre-tax charge. The company guided full-year procedure growth and margins, with strong performance across its platforms. Da Vinci system placements and procedures grew 14% and 15%, respectively.

$ISRGHighAI 8/10

Intuitive reports Q3 revenue $3.05B, GAAP EPS $1.49 and non-GAAP EPS $3.00

Intuitive Surgical reported Q3 2026 revenue of $3.05B, up 22% YoY, with GAAP EPS $1.49 and non-GAAP EPS $3.00. The results included a $450M litigation charge and a $22M tariff refund benefit. The company ended the quarter with $6.80B in cash and repurchased 7.8M shares for $2.94B. Procedure growth was 15% YoY, with da Vinci systems up 12% and Ion systems up 21%.